Dr. Rini on Sequencing of Immunotherapy Combinations in RCC

Brian I. Rini, MD, professor of Medicine, Cleveland Clinic, discusses sequencing of immunotherapy combinations for patients with renal cell carcinoma (RCC).

According to Rini, not all of the combinations are going to be getting the same amount of use, causing competition between the combination regimens.

Sequencing of these agents is still a remaining question that needs further trials to investigate, explains Rini.